UPSIDE Foods, a Berkeley, California-based company that grows meat, poultry and seafood directly from animal cells, becomes the first in the world to receive approval from the U.S. Food and Drug Administration for its lab-grown meat. The FDA said that its meat product is safe for human consumption.
According to Reuters, this is the first time that the U.S. FDA has granted such approval for cultivated meat. The US agency revealed its decision on Wednesday this week. UPSIDE Foods made chicken meat by collecting cells from live animals and using them to cultivate meat inside stainless steel tanks.
With the FDA’s approval, the company may continue with its plans to sell its products. However, in a joint statement, Robert M. Califf, M.D., the commissioner of Food and Drugs - Food and Drug Administration and Susan T. Mayne, Ph.D., the director of Center for Food Safety and Applied Nutrition (CFSAN), said that before UPSIDE Foods can fully proceed with marketing the cell-cultured meat, an inspection from the U.S. Department of Agriculture (USDA) and USDA-Food Safety and Inspection Service (FSIS) are still needed.
At any rate, the American food and drug regulator further said that it had already analyzed data from UPSIDE Foods, and it has no further questions about its conclusion that the lab-grown meat is safe to eat. But then again, the FDA explained that its review is not technically an approval and pointed out that it is only for UPSIDE products and does not apply to other companies in the same business.
"This is a watershed moment in the history of food and we started UPSIDE amid a world full of skeptics, and today, we've made history again as the first company to receive a 'No Questions' letter from the FDA for cultivated meat,” UPSIDE Foods’ founder and chief executive officer, Dr. Uma Valeti, said in a press release.
The CEO added, “This milestone marks a major step towards a new era in meat production, and I'm thrilled that U.S. consumers will soon have the chance to eat delicious meat that's grown directly from animal cells."


South Korea Warns Weak Won Could Push Inflation Higher in 2025
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Dollar Holds Firm Ahead of Global Central Bank Decisions as Yen, Sterling and Euro React
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Oil Prices Steady in Asia but Headed for Weekly Loss on Supply Glut Concerns
Asian Fund Managers Turn More Optimistic on Growth but Curb Equity Return Expectations: BofA Survey
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Asian Currencies Slip as Dollar Strengthens; Indian Rupee Rebounds on Intervention Hopes
Asian Stocks Slide as AI Spending Fears and Global Central Bank Decisions Weigh on Markets
U.S. Stock Futures Edge Higher as Micron Earnings Boost AI Sentiment Ahead of CPI Data
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
BoE Set to Cut Rates as UK Inflation Slows, but Further Easing Likely Limited 



